Market access strategy in the framework of pre- and post-marketing is a key issue in today’s competitive biopharmaceutical market environment.
Your product’s marketing potential must be demonstrated right from the start by collecting the right quality data from clinical development in order to align the payer’s expectations with real-world data prior to product launch. Two of Eurotrials’ main units – Real-World & Outcomes Research and Health Economics – work together to help you with price negotiations and communication of product added value to payers, which will give your product the best possible return through reimbursement.
Our market access consultants will work with you throughout the lifecycle of your product to map out disease profiles and plan market applications. We can either collect the evidence required to present compelling value and outcomes data to each stakeholder, or we can work with previously created databases.
Our solutions are customized according to the individual needs of our customers, always with reimbursement, targeted market access and pricing in mind:
- Market Access Strategy: Price and Reimbursement Applications
- Global Value Dossiers
- Health Technology Assessment (HTA) Submissions